According to the hospital, the vaccine is intended to prevent and slow the progression of the neurological disease. Dr. Howard L. Weiner, who led research for this vaccine, says the launch of the ...

Brigham and Women’s Hospital announced Tuesday that it would begin the first-ever human trials of a nasal vaccine to prevent and slow the progression of Alzheimer's disease.

Nasal vaccine for Alzheimer's disease to begin human trials at Boston hospital Brigham and Women's Hospital will test the safety and efficacy of a nasal vaccine aimed at preventing and slowing ...

In a new study published today in Nature, researchers from the Weizmann Institute of Science discovered that antibody-secreting cells migrate to the nasal conchae whenever we are sick or ...

Dr. Howard L. Weiner, who led research for this vaccine, says the launch of the first human trial of a nasal vaccine for Alzheimer’s is a “remarkable milestone.” ...

According to the hospital, the vaccine is intended to prevent and slow the progression of the neurological disease. Dr. Howard L. Weiner, who led research for this vaccine, says the launch of the ...

Dr. Howard L. Weiner, who led research for this vaccine, says the launch of the first human trial of a nasal vaccine for Alzheimer’s is a “remarkable milestone.” ...

Not only do the nasal conchae serve as a leading site for pathogen invasion into the airways, but they also have a major weak spot: Because they are located so close to the brain, they are not ...

Using existing and new data, the Cell study looked at multiple human, primate and mouse tissues. This study also found that nasal goblet cells highly express ACE2.